2015
DOI: 10.1016/j.molcel.2015.06.010
|View full text |Cite
|
Sign up to set email alerts
|

Pathogenic Hijacking of ER-Associated Degradation: Is ERAD Flexible?

Abstract: ER-associated degradation (ERAD) is a protein clearance mechanism by which misfolded, misassembled, or metabolically regulated proteins are specifically dislocated from the ER into the cytosol and degraded by the ubiquitin proteasome system. ERAD very likely evolved to maintain proteostasis and sterol homeostasis in the ER. However, the ironic truth is that membrane-penetrating transportation and protein degradation machineries in ERAD are preferably hijacked by exogenous pathogens such as viruses and toxins f… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
50
0

Year Published

2015
2015
2022
2022

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 50 publications
(50 citation statements)
references
References 98 publications
(132 reference statements)
0
50
0
Order By: Relevance
“…As overall M2 levels are decreased in UBR4 KO cells (Figures 5D and 5E), we hypothesized that in absence of UBR4 IAV M2 is diverted from ER to autophagosomes for degradation. The cellular endoplasmic reticulum-associated degradation (ERAD) machinery is known to target membrane proteins from ER for degradation and is frequently exploited by different viruses (Morito and Nagata, 2015). Interestingly, DBeQ, an inhibitor of the ERAD regulatory protein p97 (Dugre et al, 1990), significantly rescued both M2 total and cell surface expression (Figure S5E).…”
Section: Resultsmentioning
confidence: 99%
“…As overall M2 levels are decreased in UBR4 KO cells (Figures 5D and 5E), we hypothesized that in absence of UBR4 IAV M2 is diverted from ER to autophagosomes for degradation. The cellular endoplasmic reticulum-associated degradation (ERAD) machinery is known to target membrane proteins from ER for degradation and is frequently exploited by different viruses (Morito and Nagata, 2015). Interestingly, DBeQ, an inhibitor of the ERAD regulatory protein p97 (Dugre et al, 1990), significantly rescued both M2 total and cell surface expression (Figure S5E).…”
Section: Resultsmentioning
confidence: 99%
“…HMGR and lanosterol levels are inversely correlated, with excess HMGR being degraded by the ERAD pathway (Hampton and Garza, 2009). Pathogen-specific events can also control protein levels in the ER: the US2, US3 and US11 glycoproteins encoded by human cytomegalovirus (HCMV) co-opt the ERAD pathway to degrade Class I MHC heavy chains (Morito and Nagata, 2015). Our findings suggest a new layer of homeostatic control, in which ERAD activity itself is regulated by controlling the levels of select components through the action of UBC6e.…”
Section: Discussionmentioning
confidence: 99%
“…It represents an efficient and fast strategy developed by cells to decrease the ER lumen overflow by unfolded, misfolded, or damaged proteins. Since this pathway is not this dissertation’s main topic, it will be not described further [for more details, we suggest the following publications (18, 19)].…”
Section: Er Stress Induction and Unfolded Protein Response (Upr)mentioning
confidence: 99%